UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.81 +0.33 (+0.42%) GOLD FUTURES
2,324.50 -6.70 (-0.29%) DOW
38,882.03 +29.76 (+0.08%) Bitcoin GBP
50,658.93 +167.90 (+0.33%)
Ultragenyx Pharmaceutical Inc. (0LIF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:13PM BST
| Previous close | 42.67 |
| Open | 43.21 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 42.39 - 43.21 |
| 52-week range | 31.83 - 54.48 |
| Volume | |
| Avg. volume | 302 |
| Market cap | 24.694M |
| Beta (5Y monthly) | 0.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.87 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript May 2, 2024 Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-2.02505 EPS, expectations were $-1.72. RARE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome […]
Simply Wall St.Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its First-Quarter Results
Ultragenyx Pharmaceutical Inc. ( NASDAQ:RARE ) just released its latest first-quarter report and things are not looking...
- GuruFocus.com
Ultragenyx Pharmaceutical Inc (RARE) (Q1 2024) Earnings Call Transcript Highlights: Key ...
Explore Ultragenyx Pharmaceutical's Q1 2024 financial performance, strategic milestones, and expert insights from the latest earnings call.
© 2024 Yahoo. All rights reserved.